Skip to content

Trinity Biotech 2329360Recalls & reported problems

Clark Laboratories, Inc. · CAPTIA™ NMT Syphilis IgM · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05391516745048), received between May 18, 2021 and May 18, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Component Misassembled” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Component Misassembled1
  • Unclear Information1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 18, 2021Component Misassembled; Unclear Information; Component Misassembled; Unclear Information

    A CUSTOMER COMPLAINT WAS RECEIVED STATING THAT THE LABELS FOR THE POSITIVE AND NEGATIVE CONTROLS WERE ON THE WRONG BOTTLES. THE CUSTOMER PROVIDED PHOTOGRAPHS OF THE CONTROLS WHICH CONFIRMED THE KIT THEY HAD RECEIVED DID HAVE THE CONTROLS LABELLED INCORRECTLY. THE CUSTOMER FOUND THE ERROR PRIOR TO USING THE KIT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11841154 ↗

Other Enzyme Linked Immunoabsorption Assay, Treponema Pallidum devices

All Enzyme Linked Immunoabsorption Assay, Treponema Pallidum devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.